Publications by authors named "Raveendra Dayam"

Claim this Profile
A
A review on PARP1 inhibitors: Pharmacophore modeling, virtual and biological screening studies to identify novel PARP1 inhibitors.
Sardar Shamshair Singh, Jagarlapudi A R P Sarma, Lakshmi Narasu, Raveendra Dayam, Shili Xu

Curr Top Med Chem· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anthrax lethal factor inhibitors as potential countermeasure of the infection.
B V S Suneel Kumar, Siddharth Malik, Pradeep Grandhi, Raveendra Dayam, J A R P Sarma

Curr Top Med Chem· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis and screening studies of potent thiazol-2-amine derivatives as fibroblast growth factor receptor 1 inhibitors.
B V S Suneel Kumar, Narasu Lakshmi, M Ravi Kumar, Gundla Rambabu, Thimmappa H Manjashetty, Raveendra Dayam

Curr Top Med Chem· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of α-glucosidase inhibitors by room temperature C-C cross couplings of quinazolinones.
Ramesh Garlapati, Narender Pottabathini, Venkateshwarlu Gurram, Kumara Swamy Kasani, Rambabu Gundla, Raveendra Dayam

Org Biomol Chem· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fibroblast growth factor receptor inhibitors.
Suneel B V S Kumar, Lakshmi Narasu, Rambabu Gundla, Raveendra Dayam, Sarma J A R P

Curr Pharm Des· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insilico studies on anthrax lethal factor inhibitors: pharmacophore modeling and virtual screening approaches towards designing of novel inhibitors for a killer.
Jyoti Roy, Uday Chandra Kumar, Pavan Kumar Machiraju, Ravi Kumar Muttineni, Suneel Kumar B V S, Raveendra Dayam

J Mol Graph Model· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined pharmacophore and structure-guided studies to identify diverse HSP90 inhibitors.
Ramadevi Sanam, Sunita Tajne, Rambabu Gundla, S Vadivelan, Pavan Kumar Machiraju, Raveendra Dayam

J Mol Graph Model· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and synthesis of novel dihydroquinoline-3-carboxylic acids as HIV-1 integrase inhibitors.
Mario Sechi, Giuseppe Rizzi, Alessia Bacchi, Mauro Carcelli, Dominga Rogolino, Raveendra Dayam

Bioorg Med Chem· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacophore guided discovery of small-molecule human apurinic/apyrimidinic endonuclease 1 inhibitors.
Zahrah Zawahir, Raveendra Dayam, Jinxia Deng, Cherelene Pereira, Nouri Neamati

J Med Chem· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Four-tiered pi interaction at the dimeric interface of HIV-1 integrase critical for DNA integration and viral infectivity.
Laith Q Al-Mawsawi, Anneleen Hombrouck, Raveendra Dayam, Zeger Debyser, Nouri Neamati

Virology· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel dimeric aryldiketo containing inhibitors of HIV-1 integrase: effects of the phenyl substituent and the linker orientation.
Li-Fan Zeng, Xiao-Hua Jiang, Tino Sanchez, Hu-Shan Zhang, Raveendra Dayam

Bioorg Med Chem· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Naphthoxazepine inhibitors of HIV-1 integrase: synthesis and biological evaluation.
Antonio Garofalo, Fedora Grande, Antonella Brizzi, Francesca Aiello, Raveendra Dayam

ChemMedChem· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of novel small-molecule inhibitors of human epidermal growth factor receptor-2: combined ligand and target-based approach.
Rambabu Gundla, Roza Kazemi, Ramadevi Sanam, Ravikumar Muttineni, Jagarlapudi A R P Sarma, Raveendra Dayam

J Med Chem· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibitory profile of a LEDGF/p75 peptide against HIV-1 integrase: insight into integrase-DNA complex formation and catalysis.
Laith Q Al-Mawsawi, Frauke Christ, Raveendra Dayam, Zeger Debyser, Nouri Neamati

FEBS Lett· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quinolone 3-carboxylic acid pharmacophore: design of second generation HIV-1 integrase inhibitors.
Raveendra Dayam, Laith Q Al-Mawsawi, Zahrah Zawahir, Myriam Witvrouw, Zeger Debyser

J Med Chem· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIV-1 integrase inhibitors: 2005-2006 update.
Raveendra Dayam, Rambabu Gundla, Laith Q Al-Mawsawi, Nouri Neamati

Med Res Rev· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of novel non-cytotoxic salicylhydrazide containing HIV-1 integrase inhibitors.
Laith Q Al-Mawsawi, Raveendra Dayam, Laleh Taheri, Myriam Witvrouw, Zeger Debyser

Bioorg Med Chem Lett· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Substituted 2-pyrrolinone inhibitors of HIV-1 integrase.
Raveendra Dayam, Laith Q Al-Mawsawi, Nouri Neamati

Bioorg Med Chem Lett· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIV-1 integrase inhibitors: an emerging clinical reality.
Raveendra Dayam, Laith Q Al-Mawsawi, Nouri Neamati

Drugs R D· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of structurally diverse HIV-1 integrase inhibitors based on a chalcone pharmacophore.
Jinxia Deng, Tino Sanchez, Laith Q Al-Mawsawi, Raveendra Dayam, Rosendo A Yunes

Bioorg Med Chem· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design of second generation HIV-1 integrase inhibitors.
Jinxia Deng, Raveendra Dayam, Laith Q Al-Mawsawi, Nouri Neamati

Curr Pharm Des· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of small molecule integrin alphavbeta3 antagonists as novel anticancer agents.
Raveendra Dayam, Francesca Aiello, Jinxia Deng, Yun Wu, Antonio Garofalo

J Med Chem· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a small-molecule HIV-1 integrase inhibitor-binding site.
Laith Q Al-Mawsawi, Valery Fikkert, Raveendra Dayam, Myriam Witvrouw, Terrence R Burke

Proc Natl Acad Sci U S A· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIV-1 integrase inhibitors: 2003-2004 update.
Raveendra Dayam, Jinxia Deng, Nouri Neamati

Med Res Rev· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and structure-activity relationship studies of a unique class of HIV-1 integrase inhibitors.
Raveendra Dayam, Tino Sanchez, Nouri Neamati

ChemMedChem· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis